SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-15-023064
Filing Date
2015-04-15
Accepted
2015-04-15 17:25:24
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v407150_10qa.htm 10-Q/A 261049
2 EXHIBIT 31.1 v407150_ex31-1.htm EX-31.1 9704
3 EXHIBIT 31.2 v407150_ex31-2.htm EX-31.2 9620
4 EXHIBIT 32.1 v407150_ex32-1.htm EX-32.1 5191
5 EXHIBIT 32.2 v407150_ex32-2.htm EX-32.2 5352
  Complete submission text file 0001144204-15-023064.txt   3338454

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aphb-20140331.xml EX-101.INS 410703
7 XBRL TAXONOMY EXTENSION SCHEMA aphb-20140331.xsd EX-101.SCH 26340
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aphb-20140331_cal.xml EX-101.CAL 30523
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aphb-20140331_def.xml EX-101.DEF 174519
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aphb-20140331_lab.xml EX-101.LAB 235422
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aphb-20140331_pre.xml EX-101.PRE 207443
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-23930 | Film No.: 15772642
SIC: 2836 Biological Products, (No Diagnostic Substances)